Baseline demographic and laboratory parameters with and without new-onset AF in massive PE (only showed statistically different indicators)
| All patients (n=125) | SR (n=101) | Paroxysmal AF (n=11) | Persistent AF (n=13) | P value | |
| Congestive heart failure | 41 (36.6%) | 26 (29.2%) | 5 (50.0%) | 10 (76.9%)** | 0.003 |
| Diabetes | 7 (6.5%) | 3 (3.4%) | 2 (20.0%) | 2 (15.4%) | 0.042 |
| Heart rate (bpm) | 87±20 | 85±16 | 88±10 | 105±37**# | 0.004 |
| LVEF (%) | 49 (45–54) | 49 (46–54) | 45 (39–50)* | 46 (42–49) | 0.009 |
| Chronic cor pulmonale | 5 (4.5%) | 2 (2.2%) | 1 (10.0%) | 2 (15.4%) | 0.068 |
| LAD | 38 (30–45) | 36 (30–44) | 39 (36–48) | 47 (39–54)* | 0.019 |
| History of VTE | 33 (29.5%) | 31 (34.8%) | 1 (10.0%) | 1 (7.7%) | 0.049 |
*, **, ***: AF group vs SR group, p<0.05, p<0.01 and p<0.001, respectively.; #: paroxysmal AF group vs persistent AF group, p<0.05.
AF, atrial fibrillation; LAD, left atrium diameter; LVEF, left ventricular ejection fraction; PE, pulmonary embolism; SR, sinus rhythm; VTE, venous thromboembolism.